3.70EUR
199.67 MEUR
817.70 MEUR
18.48 M
About LABORATORIOS FARMACEUTICOS ROVI S.A.
Sector
CEO
Juan López-Belmonte Encina
Headquarters
Madrid
Website
Employees (FY)
1.99 K
Founded
1946
ISIN
ES0157261019
FIGI
BBG000QP0656
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ROVI is 79.40 EUR — it has decreased by 0.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange LABORATORIOS FARMACEUTICOS ROVI S.A. stocks are traded under the ticker ROVI.
LABORATORIOS FARMACEUTICOS ROVI S.A. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
ROVI stock is 2.25% volatile and has beta coefficient of 0.23. Check out the list of the most volatile stocks — is LABORATORIOS FARMACEUTICOS ROVI S.A. there?
One year price forecast for LABORATORIOS FARMACEUTICOS ROVI S.A. has a max estimate of 93.00 EUR and a min estimate of 60.00 EUR.
ROVI earnings for the last quarter are 0.15 EUR per share, whereas the estimation was 0.11 EUR resulting in a 36.36% surprise. The estimated earnings for the next quarter are 0.61 EUR per share. See more details about LABORATORIOS FARMACEUTICOS ROVI S.A. earnings.
LABORATORIOS FARMACEUTICOS ROVI S.A. revenue for the last quarter amounts to 214.05 M EUR despite the estimated figure of 210.56 M EUR. In the next quarter revenue is expected to reach 223.60 M EUR.
Yes, you can track LABORATORIOS FARMACEUTICOS ROVI S.A. financials in yearly and quarterly reports right on TradingView.
ROVI stock has fallen by 2.87% compared to the previous week, the month change is a 0.13% fall, over the last year LABORATORIOS FARMACEUTICOS ROVI S.A. has showed a 96.34% increase.
ROVI net income for the last quarter is 51.51 M EUR, while the quarter before that showed 52.18 M EUR of net income which accounts for −1.29% change. Track more LABORATORIOS FARMACEUTICOS ROVI S.A. financial stats to get the full picture.
Today LABORATORIOS FARMACEUTICOS ROVI S.A. has the market capitalization of 4.24 B, it has increased by 0.67% over the last week.
Yes, ROVI dividends are paid annually. The last dividend per share was 1.05 EUR. As of today, Dividend Yield (TTM)% is 1.32%. Tracking LABORATORIOS FARMACEUTICOS ROVI S.A. dividends might help you take more informed decisions.
Like other stocks, ROVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORATORIOS FARMACEUTICOS ROVI S.A. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.99 K employees. See our rating of the largest employees — is LABORATORIOS FARMACEUTICOS ROVI S.A. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LABORATORIOS FARMACEUTICOS ROVI S.A. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LABORATORIOS FARMACEUTICOS ROVI S.A. stock shows the buy signal. See more of LABORATORIOS FARMACEUTICOS ROVI S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LABORATORIOS FARMACEUTICOS ROVI S.A. future price: according to them, ROVI price has a max estimate of 93.00 EUR and a min estimate of 60.00 EUR. Read a more detailed LABORATORIOS FARMACEUTICOS ROVI S.A. forecast: see what analysts think of LABORATORIOS FARMACEUTICOS ROVI S.A. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LABORATORIOS FARMACEUTICOS ROVI S.A. EBITDA is 243.80 M EUR, and current EBITDA margin is 29.39%. See more stats in LABORATORIOS FARMACEUTICOS ROVI S.A. financial statements.